eCite Digital Repository
Prophylactic cefazolin dosing in obesity - a systematic review
Citation
Coates, M and Shield, A and Peterson, GM and Hussain, Z, Prophylactic cefazolin dosing in obesity - a systematic review, Obesity Surgery ISSN 0960-8923 (2022) [Refereed Article]
![]() | PDF Pending copyright assessment - Request a copy 1Mb |
DOI: doi:10.1007/s11695-022-06196-5
Abstract
Currently, there is no consensus on whether a standard 2-g prophylactic cefazolin dose provides sufficient antimicrobial coverage in obese surgical patients. This systematic review analysed both outcome and pharmacokinetic studies, aiming to determine the appropriate cefazolin dose. A systematic search was conducted using 4 databases. In total, 3 outcome and 15 pharmacokinetic studies met the inclusion criteria. All 3 outcome studies concluded that there is no need for increased dose. Also, 9 pharmacokinetic studies reached this conclusion; however, 6 pharmacokinetic studies recommended that 2-g dose is insufficient to achieve adequate plasma or tissue concentrations. The stronger body of evidence supports that 2-g dose of cefazolin is sufficient for surgery lasting up to 4 h; however, large-scale outcome studies are needed to confirm this evidence.
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | obesity, cefazolin, dosing, surgical site infection, prophylaxis |
Research Division: | Biomedical and Clinical Sciences |
Research Group: | Pharmacology and pharmaceutical sciences |
Research Field: | Clinical pharmacology and therapeutics |
Objective Division: | Health |
Objective Group: | Clinical health |
Objective Field: | Efficacy of medications |
UTAS Author: | Peterson, GM (Professor Gregory Peterson) |
ID Code: | 150996 |
Year Published: | 2022 |
Deposited By: | Pharmacy |
Deposited On: | 2022-07-10 |
Last Modified: | 2022-07-25 |
Downloads: | 0 |
Repository Staff Only: item control page